Alvotech Files Form 6-K for February 2025
Ticker: ALVOW · Form: 6-K · Filed: Feb 24, 2025 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
TL;DR
Alvotech filed its monthly 6-K, confirming its reporting status and Luxembourg base.
AI Summary
Alvotech, a biopharmaceutical company, filed a Form 6-K on February 24, 2025, for the month of February 2025. The company is incorporated in Luxembourg and its principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg. Alvotech is required to file annual reports under cover of Form 20-F.
Why It Matters
This filing indicates Alvotech's ongoing compliance with SEC reporting requirements as a foreign private issuer, providing transparency to investors.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer information and does not contain material new financial or operational data.
Key Players & Entities
- Alvotech (company) — Registrant
- 001-41421 (company) — SEC File Number
- 9, Rue de Bitbourg, L-1273 Luxembourg (company) — Principal executive office address
- Form 20-F (company) — Annual report form
- Form 6-K (company) — Filing type
FAQ
What is the filing date of this Form 6-K?
The filing date is February 24, 2025.
What period does this Form 6-K report on?
This Form 6-K reports for the month of February 2025.
Where is Alvotech's principal executive office located?
Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg.
What is Alvotech's SEC file number?
Alvotech's SEC file number is 001-41421.
Under which form does Alvotech file its annual reports?
Alvotech files its annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 24, 2025 regarding Alvotech (ALVOW).